Evidence map›Paper›PMID 34076172›Full record

ArticleJornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases.

Pedro Paulo Teixeira E Silva Torres, Marcelo Fouad Rabahi, Maria Auxiliadora do Carmo Moreira, Dante Luiz Escuissato, Gustavo de Souza Portes Meirelles, Edson Marchiori

Open access · diamondAbstract read
In one paragraph

Article in Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. The challenge of diagnosing interstitial lung disease by HRCT: state of the art and future perspectives.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Pedro Paulo Teixeira E Silva Torres. Multimagem Diagnósticos e Hospital Órion, Goiânia (GO) Brasil.ORCID http://orcid.org/0000-0002-8571-5667
Marcelo Fouad Rabahi. Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Goiás, Goiânia (GO) Brasil.ORCID http://orcid.org/0000-0002-4050-5906
Maria Auxiliadora do Carmo Moreira. Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Goiás, Goiânia (GO) Brasil.ORCID http://orcid.org/0000-0002-6639-0633
Dante Luiz Escuissato. Universidade Federal do Paraná, Curitiba (PR) Brasil.ORCID http://orcid.org/0000-0002-8978-4897
Gustavo de Souza Portes Meirelles. Laboratório Fleury Medicina e Saúde, São Paulo (SP) Brasil.ORCID http://orcid.org/0000-0002-4964-4160
Edson Marchiori. Departamento de Radiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro (RJ) Brasil.ORCID http://orcid.org/0000-0001-8797-7380
Universidade Federal de Goiás · BRFleury S.A. (Brazil) · BRInstituto de Olhos de Goiânia · BRUniversidade Federal do Paraná · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many conditions result in chronic interstitial lung disease (ILD), being classified as fibrosing ILDs, including idiopathic pulmonary fibrosis, connective tissue diseases, sarcoidosis, and fibrotic hypersensitivity pneumonitis. HRCT plays an important role in the clinical evaluation of fibrosing ILDs. Current treatment perspectives are encouraging and reinforce the need for HRCT scans of adequate technical quality for early detection of fibrosing ILD. Despite efforts in this regard, the significance and management of imaging findings of early interstitial lung abnormalities have yet to be clarified. After identification of CT findings consistent with fibrosing ILD, radiologists must be able to identify characteristic morphological patterns and, in some cases, features of specific clinical entities. In cases in which HRCT features are not sufficiently specific for a definitive diagnosis, HRCT can aid in selecting the best site for surgical lung biopsy. CT follow-up is useful for identifying progressive fibrosing ILDs and detecting complications unrelated to the underlying disease, including infections, acute exacerbations, and neoplasms. Automated quantification tools have clinical applicability and are likely to be available for use in imaging analysis in the near future. In addition, incorporation of CT evaluation into scoring systems based on clinical and functional parameters for staging fibrosing disease is likely to become valuable in determining prognosis. Knowledge of the clinical applications of CT evaluation is essential for specialists managing patients with fibrosing ILD and can have a positive impact on the clinical course of the disease.

Indexed as

Idiopathic Pulmonary FibrosisLung Diseases, InterstitialDisease ProgressionFibrosisHumansLung

Identifiers

PMID34076172
PMCPMC8332714
OpenAlexW3165189250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.